-
-
-
-
-
-
-
Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens as AZN Invests $2B in Strategic Equity
-
-
-
-
-
-
-
Summit Therapeutics (SMMT) Reiterated at Market Outperform by Citizens
-
-
-
-
-
-
-
Jefferies Upgrades Summit Therapeutics plc (SMMT) to Buy
-
-
-
-
-
-
-
Summit Therapeutics publishes HARMONi Phase III lung cancer trial data
-
-
-
-
-
-
-
Summit Therapeutics plc (SMMT) PT Lowered to $38 at Stifel, But 'Fundamental Conviction Intact'
-
-
-
-
-
-
-
Arcus and Summit team up to test kidney cancer drug combo
-
-
-
-
-
-
-
Bernstein SocGen Reiterates Underperform Rating on Summit Therapeutics plc (SMMT)
-
478,472 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


